GlassScriptPhysician profile
Safal Shetty
NPI 1013192384
$11,210.38
in general payments reported to CMS, 2019-2025
45 companies · $3,192 in 2025
The $3,192 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $692 · 2021: $578 · 2022: $1,909 · 2023: $2,226 · 2024: $2,033 · 2025: $3,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,379 · Travel and Lodging: $781 · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,379.33 |
| Travel and Lodging | $781.46 |
| Education | $290.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,909.88 | 2022-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,870.38 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Grifols USA, LLC | $818.15 | 2020-2025 | Prolastin-C Liquid, Xembify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $754.45 | 2019-2025 | Ofev |
| Regeneron Healthcare Solutions, INC. | $731.65 | 2021-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $682.96 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Genzyme Corporation | $627.32 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $428.12 | 2023-2025 | Purified Cortrophin Gel |
| Harmony Biosciences LLC | $382.18 | 2023-2025 | Wakix |
| Verona Pharma, INC. | $297.29 | 2025 | Ohtuvayre |
| Insmed, INC. | $279.10 | 2021-2025 | Brinsupri, Arikayce |
| Olympus Corporation of The Americas | $242.55 | 2019 | |
| Jazz Pharmaceuticals INC. | $225.28 | 2019-2025 | |
| Amgen INC. | $172.30 | 2022-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $161.17 | 2020-2025 | Glassia |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $154.03 | 2022-2023 | Acthar |
| Mylan Specialty L.P. | $116.80 | 2019-2023 | Yupelri |
| Mallinckrodt Enterprises LLC | $107.48 | 2019 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2023 | |
| Baxter Healthcare | $93.48 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| 3b Medical, INC. | $92.59 | 2025 | Luna |
| United Therapeutics Corporation | $86.52 | 2022-2025 | Tyvaso, Tyvaso |
| Fisher & Paykel Healthcare INC | $84.02 | 2022-2024 | Fisher & Paykel Healthcare |
| Merck Sharp & Dohme LLC | $72.57 | 2024-2025 | Winrevair |
| Philips North America LLC | $68.66 | 2022 | |
| Gilead Sciences, INC. | $66.12 | 2022-2025 | Veklury |
| Eisai INC. | $59.17 | 2020-2024 | |
| Pulmonx Corporation | $56.61 | 2023-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Actelion Pharmaceuticals US, INC. | $55.32 | 2023-2024 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $48.11 | 2023 | |
| Electromed, INC. | $44.11 | 2025 | Smartvest |
| Lilly USA, LLC | $42.26 | 2025 | Zepbound |
| Pfizer INC. | $33.88 | 2022-2024 | |
| Viatris Specialty LLC | $33.11 | 2025 | Yupelri |
| Ethicon INC. | $30.35 | 2025 | Monarch Platform |
| La Jolla Pharmaceutical Company | $28.65 | 2023 | Giapreza |
| Axsome Therapeutics, INC. | $26.45 | 2025 | Sunosi |
| Teva Pharmaceuticals USA, INC. | $25.58 | 2023 | Airduo Digihaler |
| Inogen, INC. | $17.43 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.13 | 2021 | |
| Abbvie INC. | $15.62 | 2023 | Ubrelvy |
| Phadia US INC. | $13.83 | 2020 | |
| Advanced Respiratory, INC | $13.66 | 2021 | |
| Circassia INC. | $13.34 | 2020 | |
| Breas Medical, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Safal Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.